Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
113802484 | 11380248 | 4 | F | 20150528 | 20160816 | 20150814 | 20160819 | PER | PHHY2015US098086 | NOVARTIS | 52.55 | YR | F | Y | 0.00000 | 20160819 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
113802484 | 11380248 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | QD | U | 22527 | CAPSULE | QD | |||||||
113802484 | 11380248 | 2 | C | CLOBETASOL | CLOBETASOL | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
113802484 | 11380248 | 1 | Multiple sclerosis |
113802484 | 11380248 | 2 | Granuloma annulare |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
113802484 | 11380248 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
113802484 | 11380248 | Basal cell carcinoma | |
113802484 | 11380248 | Cough | |
113802484 | 11380248 | Dyspnoea | |
113802484 | 11380248 | Headache | |
113802484 | 11380248 | Hot flush | |
113802484 | 11380248 | Musculoskeletal pain | |
113802484 | 11380248 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
113802484 | 11380248 | 2 | 20150528 | 0 |